AlphaMeld Corporation Expands Collaboration with Kyowa Kirin for Enterprise-Wide Access to Drug Discovery Platform

GUILFORD, Conn., Jan. 28, 2025 (GLOBE NEWSWIRE) -- AlphaMeld Corporation, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI tools to revolutionize drug discovery and development, today announced the continuation and expansion of its collaboration with Kyowa Kirin Co., Ltd. (Kyowa Kirin), a Japan-based global specialty pharmaceutical company. The enhanced partnership provides enterprise-wide access to AlphaMeld Corporation’s proprietary AI-powered Al ...